Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
According to the Global Subcutaneous Drug Delivery Market Report, by Usability (Disposable and Reusable), By Disease Indication (Auto-immune Disorders, Neurological Disorders, Oncology Disorders, Hormonal Disorders, Allergy, and Infectious Disorders, Ophthalmic Disorders, and Others), By Delivery Type (Prefilled Syringe, Injector, Prefilled Pen, Vial (Syringe), Pump and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), published by Coherent Market Insights, the global subcutaneous drug delivery market was valued at US$ 9,111.6 million in 2020, and is projected to exhibit a CAGR of 9.7% over the forecast period (2020–2027).
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/2933
Subcutaneous drug delivery is feasible alternative to intravenous administration. Prefilled syringes are used in subcutaneous drug delivery. These syringes are ready-to-use, disposable, and contain premeasured dosage. Some of the features of prefilled syringes include, reduced dosing errors, high dosing accuracy, and increased patient compliance, convenience, and safety. Such benefits are expected to propel growth of the global subcutaneous drug delivery market over the forecast period.
Moreover, increasing availability of products is also expected to aid in growth of the market. For instance, according to the study, “Growth & Benefits of Pre-Filled Syringes”, by Fisher Clinical Service, 2014, around 13 biotechnology products were available commercially in the market in 1989, which increased to 210 in 2012. As per Fisher Clinical Service, in 2013, the prefilled syringes segment was expected to account for a quarter of the total injectables drug delivery systems, which included around 35 of the 100 top-selling drugs, which were to be incorporated in the form of injection.
Apply Promo Code “STAYHOME” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2933
Major players in the market are focused on launching new products to expand their product portfolio. For instance, in December 2016, Becton, Dickinson and Company launched BD Neopak 2.25 mL prefillable glass syringe, for biopharmaceutical manufacturers focused on manufacturing sensitive biologic drugs for the treatment of chronic diseases such as rheumatoid arthritis, psoriasis, lupus, and severe asthma. The syringe offers higher volume subcutaneous injections and aids to improve safety and convenience for patients.
The performance of currently available products is optimum only at specific temperatures. Thus, development and launch of novel epinephrine auto injectors that offer thermal stability is expected to offer lucrative growth opportunities for players in the global subcutaneous drug delivery market. For instance, Windgap Medical is focused on developing a portable device that would mix a dry formulation of the drug into solution, thus providing temperature stability and a longer shelf-life of medication, for patients suffering from anaphylaxis due to an acute allergy attack.
To know the latest trends and insights prevalent in the global subcutaneous drug delivery market press release, click the link below: https://bit.ly/2IZ8Jmj
Among usability, the disposable segment is expected to account for higher market share in 2018, owing to significant increase in self-administration of drugs for the treatment of chronic diseases.
Among disease indication, autoimmune disorders segment is expected to account for a higher market share in 2018, owing to increasing prevalence of autoimmune diseases such as multiple sclerosis and new approvals for injector devices
Key Takeaways
- The global subcutaneous drug delivery market is expected to exhibit a CAGR of 9.7% over the forecast period
- Major players operating in the global subcutaneous drug delivery market include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Sanofi S.A., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, and Merck & Co., Inc.
Other Related Reports:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
